<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Sirtuin (SIRT)3 is a <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> protein deacetylase that regulates reactive oxygen species (ROS) production and exerts anti-inflammatory effects </plain></SENT>
<SENT sid="1" pm="."><plain>As <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction are key factors mediating pancreatic beta cell impairment in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, we investigated the role of SIRT3 in the maintenance of beta cell function and mass in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We analysed changes in SIRT3 expression in experimental models of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and in human islets isolated from type 2 diabetic patients </plain></SENT>
<SENT sid="3" pm="."><plain>We also determined the effects of SIRT3 knockdown on beta cell function and mass in INS1 cells </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: SIRT3 expression was markedly decreased in islets isolated from type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients, as well as in mouse islets or INS1 cells incubated with IL1β and TNFα </plain></SENT>
<SENT sid="5" pm="."><plain>SIRT3 knockdown in INS1 cells resulted in lowered insulin secretion, increased beta cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and reduced expression of key beta cell genes </plain></SENT>
<SENT sid="6" pm="."><plain>SIRT3 knockdown also blocked the protective effects of <z:chebi fb="0" ids="50383">nicotinamide mononucleotide</z:chebi> on pro-inflammatory cytokines in beta cells </plain></SENT>
<SENT sid="7" pm="."><plain>The deleterious effects of SIRT3 knockdown were mediated by increased levels of cellular ROS and IL1β </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS/INTERPRETATION: Decreased beta cell SIRT3 levels could be a key step in the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0006279'>beta cell dysfunction</z:hpo>, occurring via abnormal elevation of ROS levels and amplification of beta cell IL1β synthesis </plain></SENT>
<SENT sid="9" pm="."><plain>Strategies to increase the activity or levels of SIRT3 could generate attractive therapies for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>